Exercise & Cancer Protection
The lever with the best evidence
Physical activity is one of the most robust anti-cancer levers in epidemiology. The effect size across observational + interventional studies is large and consistent across multiple cancers. It's also the lever most people underdose on.
Moore et al. — 13 cancer sites
In a 2016 JAMA Internal Medicine pooled analysis of 1.44 million adults, higher physical activity was associated with lower risk of 13 cancer types — including esophageal (−42%), liver (−27%), lung (−26%), kidney (−23%), and gastric cardia (−22%). Risk reductions were robust to smoking and BMI adjustment.
The mechanism stack
Exercise lowers cancer risk through many overlapping pathways: reduced visceral fat (inflammation + hormones), improved insulin sensitivity (IGF-1), better immune surveillance (NK-cell function), reduced systemic inflammation (IL-6, TNF-α), improved bowel transit (colon cancer), and better hormone clearance (breast + endometrial).
Exercise during + after cancer treatment
The ACSM updated its exercise-during-cancer guidelines in 2019: exercise is safe, recommended, and associated with 30–50% reduction in all-cause mortality in multiple cancer survivor cohorts. Active cancer patients who exercise have better treatment tolerance, recovery, and long-term outcomes.
Which exercise protocol wins?
Pick the evidence-based target for cancer-prevention dose.
This step is interactive — open the Thier app to try it.
Key Takeaway
Exercise is the most evidence-backed cancer-prevention lever that isn't a drug. 150 min/week moderate aerobic + 2 resistance sessions + sedentary time under 8 hr/day targets the mechanisms most tied to cancer risk. Same prescription as cardiovascular + dementia prevention — one dose, three protections.